Targeting metabolic cell death in cancer to reverse drug resistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-11 · 1881 (6) · 189737
DOI: 10.1016/j.bbcan.2026.189737 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-11. Verfasst von Tingting Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, State Key Laboratory of Biotherapy, Sichuan University, Tianfu Jincheng Laboratory…. Die Arbeit nennt 168 Literaturangaben.
Abstract (Originalsprache)
Evasion of apoptosis is a typical feature of malignant tumors developing to survive therapeutic stress. As a result, chemotherapeutic drugs that primarily induce apoptosis can no longer effectively kill tumor cells, which brings challenges to clinical cancer treatment. Recent evidence indicates that targeting key nodes in cellular metabolic pathways can bypass apoptotic routes and induce metabolic cell death in tumor cells to overcome drug resistance. Different from the traditional ways of defining cell death that rely on morphological features, metabolic cell death focuses more on the inducing factors and the associated dysregulation of cellular metabolic pathways. Metabolic cell death can be classified into four categories based on the driver factors of cell death: (1) metal ion dyshomeostasis-mediated cell death; (2) redox-collapse cell death; (3) pH dyshomeostasis-driven cell death; and (4) metabolic byproduct accumulation-mediated cell death. According to these metabolic cell death patterns, several therapeutic strategies targeting the metabolic vulnerabilities have attracted considerable attention. Here, we summarize the major metabolic cell death patterns of tumor cells, examine how these death modalities engage anti-tumor immunity, and discuss how exploiting them can reverse drug resistance. We further discuss the therapeutic window, tumor metabolic heterogeneity, and metabolic network therapeutic implications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China School of Public Health and West China Fourth Hospital, State Key Laboratory of Biotherapy, Sichuan University, Tianfu Jincheng Laboratory, Chengdu, 610041, China.
- Department of Ultrasonic Medicine, West China Second University Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Che…
- Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, 453100, China.
- Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610041, Chin…
- Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, 453100, China; Department of Neurosurgery, Medical Research Center, The Affiliated Hospital of Southwest Jiao…
- West China School of Public Health and West China Fourth Hospital, State Key Laboratory of Biotherapy, Sichuan University, Tianfu Jincheng Laboratory, Chengdu, 610041, China; Department of Oncology, The First Affiliated…
Zitieren
APA
Liu, T., Dang, Y., Zhang, W., Liu, Y., Ji, Y., Lu, P., Zou, H., Yang, W., & Jiang, J. (2026). Targeting metabolic cell death in cancer to reverse drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(6), 189737. https://doi.org/10.1016/j.bbcan.2026.189737
Vancouver
Liu T, Dang Y, Zhang W, Liu Y, Ji Y, Lu P, et al. Targeting metabolic cell death in cancer to reverse drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(6):189737. doi:10.1016/j.bbcan.2026.189737
BibTeX
@article{Liu2026,
author = {Liu, Tingting and Dang, Yixiong and Zhang, Wen and Liu, Yanting and Ji, Yinghua and Lu, Ping and Zou, Haimin and Yang, Wenyong and Jiang, Jingwen},
title = {Targeting metabolic cell death in cancer to reverse drug resistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {6},
pages = {189737},
doi = {10.1016/j.bbcan.2026.189737}
}
EUVIMED